Dosley guides

What to track during a GLP-1 routine

Which details to write down during a GLP-1 routine, from injection dates and body region to pen supply, symptoms, and questions for your next appointment.

Author
Stefan Creanga, Dosley developer
Last reviewed
Review method
Source and boundary checks

GLP-1 tracking works best when it is boring in a good way. You are not trying to diagnose yourself or build a treatment plan. You are keeping the facts that make weekly routines, pharmacy calls, and provider appointments easier to reconstruct.

For the broader injection overview, read the GLP-1 injection guide.

The core weekly entry

For injectable GLP-1 medications, labels commonly frame the routine around a weekly subcutaneous injection. Ozempic and Wegovy labels list the abdomen, thigh, and upper arm as injection regions; Mounjaro and Zepbound labels list the abdomen or thigh for the patient and the back of the upper arm when another person gives the injection. Each label uses product-specific rotation language. (Ozempic PI; Wegovy PI; Mounjaro PI; Zepbound PI)

A useful weekly entry can include:

  • date and time
  • medication name
  • dose as prescribed
  • injection body region
  • site-rotation note
  • pen or device note
  • symptom or observation to discuss later

The words “as prescribed” matter. A tracker should reflect the routine you were given, not invent a new one.

Separate observations from conclusions

Good notes are descriptive. “Nausea after dinner” is a note. “This means my dose is wrong” is a medical conclusion. Dosley should help with the first and leave the second to a clinician.

This is especially important when you notice patterns. A log can help you remember what happened, but it cannot decide whether the pattern is caused by medication, meals, illness, timing, or something else.

Track the practical details too

Some of the most useful GLP-1 records are not dramatic:

  • which pen you opened
  • first-use date
  • remaining expected supply
  • storage question
  • pharmacy refill note
  • travel dates
  • provider question

Ozempic’s label includes both dose-count and storage details, which is why supply tracking and storage tracking should stay separate. (Ozempic PI)

For dose-count arithmetic, see How long does an Ozempic pen last?. For storage, see How to store GLP-1 medications correctly.

Bring better questions to appointments

The best use of a tracker is often the question list it creates. Instead of trying to remember a month of details, you can bring a short timeline:

  • dates injections happened
  • sites used
  • missed or delayed events
  • symptoms or observations
  • storage or travel questions
  • refill timing questions

Dosley’s free printable injection log gives these details a simple paper format. It records your history without deciding what your routine should be.

If a scheduled injection slips, read Missed a GLP-1 dose?, which quotes the Ozempic and Wegovy missed-dose sections in full, then bring your situation to your prescriber or pharmacist. Mounjaro, Zepbound, and other products are not quoted there, so use the current label for the product you have and your care team’s instructions instead. (Ozempic PI; Wegovy PI; Mounjaro PI; Zepbound PI)

For site-specific notes, see Injection site rotation. For travel routines, see Traveling with GLP-1 pens.

For medication-specific background, see Dosley’s Ozempic, Wegovy, Mounjaro, and Zepbound pages.

Questions covered in this guide

Is GLP-1 tracking medical advice?

No. Tracking is a recordkeeping habit. Treatment decisions belong with your healthcare provider.

How much should I track?

Start with the few details you can keep consistently, then add notes your care team asks you to bring.

Track your routine

Keep injection notes, symptoms, weight, and pen supply together.

Open the GLP-1 tracker page

References

  1. Ozempic (semaglutide) injection prescribing information Novo Nordisk Revised 05/2026
  2. Wegovy (semaglutide) injection and tablets prescribing information Novo Nordisk Revised 06/2026
  3. Mounjaro (tirzepatide) prescribing information Eli Lilly and Company Revised 04/2026
  4. Zepbound (tirzepatide) prescribing information Eli Lilly and Company Revised 04/2026